Autobahn Therapeutics

Autobahn Therapeutics

Latest funding
$76,000,000
Venture capital (Series B) - 2020
ARCH Venture Partners Invus Biotechnology Value Fund +7
Team Size
1–10
Employees
$76,000,000 Venture capital (Series B)
Pulse 2.0

Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders

FinSMEs

Autobahn Therapeutics Raises $76M in Series B Financing